Yonghui Shi

Guangdong Provincial Key Laboratory Of Malignant Tumor Epigenetics And Gene Regulation
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Enhancing chemo-immunotherapy in triple-negative breast cancer: Co-delivery of doxorubicin and berberine using nanoparticles to downregulate PD-L1 and eliminate cancer stem cells.

Enhancing chemo-immunotherapy in triple-negative breast cancer: Co-delivery of doxorubicin and berberine using nanoparticles to downregulate PD-L1 and eliminate cancer stem cells.

Journal: International journal of pharmaceutics

Published: October 28, 2024

Mechanism of Apigenin against breast cancer stem cells: network pharmacology and experimental validation.

Mechanism of Apigenin against breast cancer stem cells: network pharmacology and experimental validation.

Journal: Frontiers in pharmacology

Published: September 15, 2024

Ginsenoside Rg3 attenuates the stemness of breast cancer stem cells by activating the hippo signaling pathway.

Ginsenoside Rg3 attenuates the stemness of breast cancer stem cells by activating the hippo signaling pathway.

Journal: Toxicology and applied pharmacology

Published: July 23, 2024

A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs.

A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs.

Journal: Biomaterials research

Published: September 19, 2023

Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification.

Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification.

Journal: Frontiers in pharmacology

Published: April 14, 2022

Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting.

Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting.

Journal: International journal of nanomedicine

Published: September 15, 2020

Oligosaccharide-camptothecin conjugates as potential antineoplastic drugs: Design, synthesis and biological evaluation.

Oligosaccharide-camptothecin conjugates as potential antineoplastic drugs: Design, synthesis and biological evaluation.

Journal: European journal of medicinal chemistry

Published: April 15, 2020

Design and synthesis of α-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation.

Design and synthesis of α-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation.

Journal: European journal of medicinal chemistry

Published: October 15, 2019

Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.

Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.

Journal: Journal of biomedical nanotechnology

Published: June 17, 2016

Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.

Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.

Journal: Oncotarget

Published: October 30, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026